Tapentadol in neuropathic pain cancer patients: a prospective open label study
Many chemotherapy treatments induce peripheral neuropathy (CIPN). These patients often experience neuropathic pain (NP) that reduces the quality of life. The aim of this prospective, open label study was to evaluate the efficacy and tolerability of tapentadol (TP) in patients affected by CIPN. CIPN...
Saved in:
Published in | Neurological sciences Vol. 38; no. 10; pp. 1747 - 1752 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Milan
Springer Milan
01.10.2017
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!